Efficacy and safety of bevacizumab with standard first-line fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer: First beat

被引：0

作者：

Rivera, F.

Cunningham, D. ^{[1
]}

Berry, S. ^{[2
]}

Kretzschmar, A. ^{[3
]}

Michael, M. ^{[4
]}

Dibartolomeo, M. ^{[5
]}

Mazier, M. ^{[6
]}

Andre, N. ^{[7
]}

Van Cutsem, E. ^{[8
]}

机构：

[1] Royal Marsden Hosp, Dept Med, Sutton, Surrey, England

[2] Sunnybrook Hlth Sci Ctr, Div Haematol Med Oncol, Toronto, ON M4N 3M5, Canada

[3] HELIOS Klin, Robert Rossle Klin, Charite, Berlin, Germany

[4] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia

[5] Ist Nazl Tumori, Div Med Oncol, Unit 2, I-20133 Milan, Italy

[6] Paraxel, Dept Stat, Paris, France

[7] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland

[8] Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, Belgium

来源：

ANNALS OF ONCOLOGY | 2008年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：17 / 17

页数：1

共 50 条

[1] SAFETY AND EFFICACY OF BEVACIZUMAB PLUS STANDARD FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER: FIRST BEAT
Van Cutsem, E.
Berry, S.
Michael, M.
Kretzschmar, A.
Rivera, F.
DiBartolomeo, M.
Mazier, M.
Andre, N.
Cunningham, D.
[J]. ANNALS OF ONCOLOGY, 2008, 19 : 125 - 125
[2] Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer
Whyte, S.
Pandor, A.
Stevenson, M.
Rees, A.
[J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 47 - 53
[3] Safety of bevacizumab with fluoropyrimidine-based regimens for first-line teatment of metastatic colorectal cancer
Tyagi, Preeta
Chu, Edward
[J]. CLINICAL COLORECTAL CANCER, 2006, 6 (03) : 189 - 191
[4] Efficacy and safety of surgery with curative intent in patients treated with first-line Bevacizumab plus chemotherapy for metastatic colorectal cancer: First beat
Kretzschmar, A.
Cunningham, D.
Berry, S.
Rivera, F.
Di Bartolomeo, M.
Mazier, M.
Van Cutsem, E.
[J]. ANNALS OF ONCOLOGY, 2008, 19 : I25 - I25
[5] Final efficacy results for bevacizumab plus standard first-line chemotherapies in patients with metastatic colorectal cancer: First BEAT
Berry, S. R.
Van Cutsem, E.
Kretzschmar, A.
Michael, M.
Rivera, F.
DiBartolomeo, M.
Mazier, M. A.
Andre, N.
Cunningham, D.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[6] Efficacy and safety of first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a meta-analysis
Wang Ming
Zheng Xiaofeng
Ruan Xiaojiao
Ye Bailiang
Cai Long
Lin Feizhuan
Tu Jinfu
Jiang Feizhao
Li Shaotang
[J]. CHINESE MEDICAL JOURNAL, 2014, 127 (03) : 538 - 546
[7] Optimizing the Efficacy of First-Line Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer
Shaotang Li
Pan Dr Chi
[J]. BioDrugs, 2011, 25 : 43 - 50
[8] Safety and efficacy of first-line chemotherapy in unresected metastatic colorectal cancer
Puthillath, Ajithkumar
Dunn, Kelli Bullard
Rajput, Ashwani
Smith, Judy
Yang, Gary
Wilding, Gregory E.
Tan, Wei
Gupta, Bhavna
Fakih, Marwan G.
[J]. CLINICAL COLORECTAL CANCER, 2007, 6 (10) : 710 - 715
[9] Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
Van Cutsem, E.
Rivera, F.
Berry, S.
Kretzschmar, A.
Michael, M.
DiBartolomeo, M.
Mazier, M. -A.
Canon, J. -L.
Georgoulias, V.
Peeters, M.
Bridgewater, J.
Cunningham, D.
[J]. ANNALS OF ONCOLOGY, 2009, 20 (11) : 1842 - 1847
[10] Addition of Bevacizumab to First-Line Chemotherapy for Metastatic Colorectal Cancer
Tsutsumi, Soichi
Fujii, Takaaki
Yamaguchi, Satoru
Suto, Toshinaga
Yajima, Reina
Morita, Hiroki
Kato, Toshihide
Asao, Takayuki
Kuwano, Hiroyuki
[J]. HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 633 - 637

← 1 2 3 4 5 →